Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Assets (2016 - 2025)

Historic Return on Assets for Sunshine Biopharma (SBFM) over the last 12 years, with Q3 2025 value amounting to 0.19%.

  • Sunshine Biopharma's Return on Assets fell 500.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.18% for FY2024, which is 200.0% down from last year.
  • Per Sunshine Biopharma's latest filing, its Return on Assets stood at 0.19% for Q3 2025, which was down 500.0% from 0.21% recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Return on Assets registered a high of 0.06% during Q3 2022, and its lowest value of 6.07% during Q3 2021.
  • In the last 5 years, Sunshine Biopharma's Return on Assets had a median value of 0.21% in 2025 and averaged 1.41%.
  • In the last 5 years, Sunshine Biopharma's Return on Assets soared by 60100bps in 2022 and then tumbled by -8900bps in 2023.
  • Over the past 5 years, Sunshine Biopharma's Return on Assets (Quarter) stood at 5.29% in 2021, then surged by 86bps to 0.76% in 2022, then surged by 79bps to 0.16% in 2023, then fell by -3bps to 0.17% in 2024, then decreased by -12bps to 0.19% in 2025.
  • Its Return on Assets was 0.19% in Q3 2025, compared to 0.21% in Q2 2025 and 0.17% in Q1 2025.